Sectors
Health, BioTech
Headquarters
257 Park Ave South 2nd Floor New York, New York, 10010, United States
CEO
Arif Nathoo
Komodo Health shares, as of April 21, 2025, are valued at a price per share implying an approximate -2.84% relative to the most recent significant secondary market activity in June 2022, according to PM Insights' market data. PM Insights uses a market-driven derived price methodology to determine Komodo Health's valuation when recent secondary market transactions are limited or unavailable, as is currently the case for Komodo Health.
Register today to view the full report, with more in-depth details and analytics
Latest funding round
XXXXX
XX-XX-XXXX
AV Implied Valuation
XXXXX
XX-XX-XXXX
Change since Last Round
XXXXX
XX-XX-XXXX
Secondary Activity
XXXXX
Business Partnerships
Targeted Impact
Who Will Benefit?
What Comes Next?
No items found.
.png)
Komodo Health generated $284.0M in revenue as of 2024, according to PM Insights' market research.
Komodo Health shares, as of April 21, 2025, are valued at a price per share implying an approximate -2.84% relative to the most recent significant secondary market activity in June 2022, according to PM Insights' market data. PM Insights uses a market-driven derived price methodology to determine Komodo Health's valuation when recent secondary market transactions are limited or unavailable, as is currently the case for Komodo Health.
No items found.
No items found.
Ready to see it in action?
Schedule a demo with one of our experts
